Legendary licenses

Scienmag

Licensing expert Bob Westervelt, who has worked to transfer Sandia National Laboratories technologies in the medical, solar and hydrogen production fields, received the 2021 Outstanding Technology Transfer Professional Award from the Federal Laboratory Consortium.

Should e-cigarettes be licensed as medicines?

Scienmag

Latest News Ecigarettes licensed MedicinesNicholas Hopkinson at Imperial College London welcomes the move, saying this will give doctors another means to help smokers quit. E-cigarettes are currently regulated as consumer products so cannot be promoted as smoking cessation aids, he explains. Yet a Cochrane review already supports existing e-cigarettes as a smoking cessation aid, as does recently updated guidance […].

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Biogen licenses a stroke drug from Japanese drugmaker TMS

Bio Pharma Dive

The drug, which Biogen had an option to license, is one of two in the biotech's pipeline for a condition that has had few new treatments developed

Ignis Therapeutics Licenses NeuroSigma eTNS Technology for ADHD in a Significant China Licensing Transaction

BioTech 365

Ignis Therapeutics Licenses NeuroSigma eTNS Technology for ADHD in a Significant China Licensing Transaction Ignis Therapeutics Licenses NeuroSigma eTNS Technology for ADHD in a Significant China Licensing Transaction Ignis obtains rights to develop and commercialize NeuroSigma’s FDA-approved Monarch eTNS System in China … Continue reading → GlobeNewswire

Merck agrees to license COVID-19 pill widely through pact with patent group

Bio Pharma Dive

The deal with the Medicines Patent Pool is meant to increase access in lower-income countries to molnupiravir, an experimental drug that could become the first oral treatment for COVID-19

Ignis Health licenses telehealth roadmap from the Medical University of South Carolina

Scienmag

Technology and Engineering Biotechnology Health Care Systems/Services Health Professionals Information Management/Tracking Systems Licenses/Patents Management Science/Operations Research Medicine/Health Technology Transfer Telecommunications

VaxAlta Inc. Announces License Agreement With Scandinavian Biopharma

BioTech 365

Announces License Agreement With Scandinavian Biopharma VaxAlta Inc. Announces License Agreement With Scandinavian Biopharma Scandinavian Biopharma has obtained a global license for VaxAlta Inc.’s VaxAlta Inc.

Ligand and GSK Expand Global Collaboration and License Agreement

BioTech 365

Ligand and GSK Expand Global Collaboration and License Agreement Ligand and GSK Expand Global Collaboration and License Agreement Ligand to receive an upfront payment of $10 million Further leverages the Icagen ion-channel discovery technology to target neurological diseases EMERYVILLE, Calif.–(BUSINESS

Eikonoklastes Bolsters Pipeline, Announces a License for Novel Gene Therapy to Address Neurodegenerative Diseases

BioTech 365

Companies Enter Licensing Agreements to Expand Gene Therapy Programs

BioSpace

Takeda entered into a licensing pact with Poseida, Spark entered into a licensing agreement with CombiGene AB, while BridgeBio Pharma announced plans for its second annual R&D Day

MHRA licenses Ryeqo for symptoms of uterine fibroids

Pharma Times

First oral GnRH antagonist to be licensed in Great Britain for these women

The Lundquist Institute out-licenses development of a synthetic lung surfactant formulation

Scienmag

Bill & Melinda Gates Medical Research Institute to develop formulation -AGREEMENT ADVANCES EVOLUTION OF SYNTHETIC LUNG SURFACTANTS TO TREAT RESPIRATORY DISTRESS SYNDROME IN PREMATURE INFANTS IN LOW- AND MIDDLE-INCOME COUNTRIES- LOS ANGELES (March 8, 2021) — The Lundquist Institute (TLI) and The Bill & Melinda Gates Medical Research Institute (Gates MRI) executed a license agreement […].

Avacta Signs Diagnostic Licensing Deal with Biokit

BioTech 365

Heritage Granted Health Canada Research License

BioTech 365

Heritage Granted Health Canada Research License Heritage Granted Health Canada Research License TORONTO–(BUSINESS WIRE)–Heritage Cannabis Holdings Corp.

FibroGen Exercises Exclusive License Option for HiFiBiO’s CCR8 Program

BioTech 365

FibroGen Exercises Exclusive License Option for HiFiBiO’s CCR8 Program FibroGen Exercises Exclusive License Option for HiFiBiO’s CCR8 Program Exclusive license to anti-CCR8 monoclonal antibody program further strengthens FibroGen’s preclinical development pipeline HiFiBiO to receive $35 million option exercise payment, potential … Continue reading → GlobeNewswire

Akili adds to ADHD gaming range with £37m TALi licensing deal

Pharma Phorum

Akili already has the first and only FDA cleared video game-based digital therapeutic (DTx) for children with attention-deficit hyperactivity disorder (ADHD), but is looking to add to its range via a licensing deal with Australia’s TALi Digital. .

Boston Pharmaceuticals Licenses Potential NASH Treatment from Novartis

BioSpace

Boston Pharmaceuticals licensed the drug candidate BOS-580, an injectable, genetically engineered variant of human FGF21

ERS Genomics and Cellular Engineering Technologies Enter CRISPR/Cas9 License Agreement

BioTech 365

Pfizer and OPKO Provide Update on the Biologics License Application for Somatrogon for Pediatric Growth Hormone Deficiency

BioTech 365

Pfizer and OPKO Provide Update on the Biologics License Application for Somatrogon for Pediatric Growth Hormone Deficiency Pfizer and OPKO Provide Update on the Biologics License Application for Somatrogon for Pediatric Growth Hormone Deficiency NEW YORK & MIAMI–(BUSINESS WIRE)–Pfizer Inc.

CinFina Pharma In-Licenses Obesity Portfolio

BioTech 365

CinFina Pharma In-Licenses Obesity Portfolio CinFina Pharma In-Licenses Obesity Portfolio Four novel, once-weekly anorectic agents targeting significant weight loss CINCINNATI, Sept. 22, 2021 (GLOBE NEWSWIRE) — CinFina Pharma, LLC. CinFina”) announced today that it has signed an agreement with Janssen … Continue reading → GlobeNewswire

UK biotech and University of Birmingham in licensing deal for nasal spray targeting COVID-19

BioPharma Reporter

Birmingham Biotech and the University of Birmingham have signed a licensing agreement for an anti-viral nasal spray against COVID-19. Markets & Regulations

ERS Genomics and Nippon Gene sign CRISPR/Cas9 license agreement

BioTech 365

UK biotech and University of Birmingham licensing deal for nasal spray targeting COVID-19

BioPharma Reporter

Birmingham Biotech and the University of Birmingham have signed a licensing agreement for an anti-viral nasal spray against COVID-19. Markets & Regulations

ADC Therapeutics Announces Exclusive License with Mitsubishi Tanabe Pharma Corporation to Develop and Commercialize ZYNLONTA® (loncastuximab tesirine-lpyl) in Japan

BioTech 365

BMS Licenses IL-12 from Dragonfly in $475 Million Deal

BioSpace

Bristol Myers Squibb plunked down $475 million for the exclusive license to Dragonfly Therapeutics’ interleukin-12 (IL-12) investigational immunotherapy program

Lilly adds to pain pipeline with Asahi Kasei licensing deal

Pharma Phorum

US drugmaker Eli Lilly – still waiting for an FDA decision on one non-opioid pain drug – has just added another to its pipeline via a licensing agreement with Japan’s Asahi Kasei worth up to $410 million. The post Lilly adds to pain pipeline with Asahi Kasei licensing deal appeared first on.

Chinese tech giant Baidu licenses mRNA algorithm to Sanofi

Pharma Phorum

Sanofi has bolstered its push into mRNA-based therapies with a new licensing deal – but not as might be expected with some up-and-coming biotech company. The post Chinese tech giant Baidu licenses mRNA algorithm to Sanofi appeared first on.

ERS Genomics and GenScript Biotech Corporation sign CRISPR/Cas9 license agreement

BioTech 365

ERS Genomics and GenScript Biotech Corporation sign CRISPR/Cas9 license agreement ERS Genomics and GenScript Biotech Corporation sign CRISPR/Cas9 license agreement License agreement to enhance GenScript’s CRISPR offering for gene and cell therapy research DUBLIN & PISCATAWAY, N.J.–(BUSINESS

Gene 52

SINOVAC Beijing Settled Litigation of Its Business License and Seals

BioTech 365

SINOVAC Beijing Settled Litigation of Its Business License and Seals SINOVAC Beijing Settled Litigation of Its Business License and Seals BEIJING–(BUSINESS WIRE)–SINOVAC Biotech Ltd. NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, announced the … Continue reading → Business Wire

Allecra Therapeutics and ADVANZ PHARMA Sign Exclusive License and Supply Agreement for Allecra’s Antibiotic Cefepime/enmetazobactam in Europe

BioTech 365

Cytiva licenses Allen Institute’s advanced machine learning technology

Scienmag

Strategic license to advance the field of 3D and live cell imaging Credit: Allen Institute Cytiva and the Allen Institute have entered into a license agreement to integrate the Allen Institute’s machine learning technology with Cytiva’s microscopy and image analysis systems to advance the development of cell imaging innovations.

ERS Genomics and Japan SLC Sign CRISPR/Cas9 License Agreement

BioTech 365

ERS Genomics signs CRISPR license agreement with Otsuka

Pharma Times

License grants Otsuka access to CRISPR/Cas9 genome editing technology

JenaValve Announces Strategic Investment and Licensing Agreement with Peijia Medical Limited

BioTech 365

JenaValve Announces Strategic Investment and Licensing Agreement with Peijia Medical Limited JenaValve Announces Strategic Investment and Licensing Agreement with Peijia Medical Limited IRVINE, Calif., 18, 2022 (GLOBE NEWSWIRE) — JenaValve Technology, Inc. JenaValve” or the “Company”), developer and manufacturer … Continue reading → GlobeNewswire

Iksuda Therapeutics Deepens Clinical Pipeline Through Licensing Agreement for Her2 Antibody Drug Conjugate Programme From LegoChem Biosciences

BioTech 365

Xlife Sciences AG: Successful license deal with Vitese Trading GmbH

BioTech 365

DGAP-Media / 07.10.2021 / 09:05 MEDIA INFORMATION Xlife Sciences AG (XLS DE): Successful license deal with Vitese Trading GmbH Inflamed pharma GmbH signs license agreement with Vitesse Trading GmbH The Xlife-project company inflamed pharma GmbH has concluded an exclusive license … Continue reading → EQS Newsfeed

Lonza and Doer Biologics in expression system license deal

BioPharma Reporter

Lonza has signed a licensing agreement with clinical-stage biopharma, Zhejiang Doer Biologics, whereby the Hangzhou, China based biopharma company will develop multi-specific biotherapeutics using the Swiss CDMOâs XS Pichia.

ERS Genomics Licenses CRISPR Gene Editing Technology to Otsuka Pharmaceutical

BioTech 365

Sierra Oncology licenses myelofibrosis candidate from AstraZeneca

Pharma Times

Planned Phase II study to combine the BET inhibitor with momelotinib

Proteros Enters Into Oncology Collaboration and License Agreement With AstraZeneca

BioTech 365

Arrowhead Pharmaceuticals Enters Exclusive License Agreement with GSK for ARO-HSD

BioTech 365

Arrowhead Pharmaceuticals Enters Exclusive License Agreement with GSK for ARO-HSD Arrowhead Pharmaceuticals Enters Exclusive License Agreement with GSK for ARO-HSD – Upon closing, Arrowhead to receive $120 million upfront payment for Phase 1/2 program for NASH – Arrowhead eligible to … Continue reading → Business Wire

 Lysogene Announces Termination of License Agreement With Sarepta for LYS-SAF302 Program, Regaining Global Commercial Rights

BioTech 365

Lysogene Announces Termination of License Agreement With Sarepta for LYS-SAF302 Program, Regaining Global Commercial Rights Lysogene Announces Termination of License Agreement With Sarepta for LYS-SAF302 Program, Regaining Global Commercial Rights Lysogene remains focused on developing its pipeline led by LYS-SAF302, … Continue reading → Business Wire

Hubrecht Institute Licenses Flow Eighteen38 Reagent Antibodies for Cancer Research

BioTech 365

Hubrecht Institute Licenses Flow Eighteen38 Reagent Antibodies for Cancer Research Hubrecht Institute Licenses Flow Eighteen38 Reagent Antibodies for Cancer Research Antibodies generated by Flow Eighteen38 to be used as research tools by Hubrecht Institute.